wax su'aalo ah ma qabtaa?        +86- 18112515727        song@orthopedic-china.com
Please Choose Your Language
Halkan Guriga joogtaa Wararka ayaad Laf dhabarta

Naqshad Cusub oo R&D Nidaamka Lafdhabarta Ugu Yar (MIS)

Aragtida: 0     Qore: Tifaftiraha Goobta Waqtiga Daabacaadda: 2025-03-31 Asal: Goobta

badhanka wadaaga facebook
badhanka wadaaga twitter
badhanka wadaaga khadka
badhanka wadaaga wechat
linkin wadaaga badhanka
badhanka wadaaga pinterest
la wadaag badhanka wadaagga

Naqshadaynta R&D cusub

MIS | Casriyeynta Farsamada - Faa'iidooyinka Farsamada - Natiijooyinka Qalliinka Kadib | czmeditech

Nidaamka Laf-dhabarta ee Ugu Yar (MIS) waa tignoolajiyada casriga ah ee suurtageliya daaweynta saxda ah iyada oo loo marayo jeexjeexyo yaryar oo xaaladaha sida saxannada herniated iyo stenosis laf dhabarta.

Faahfaahin naqshad cusub


Faa'iidooyinka ugu yar ee duulaanka ah

Dhaawaca la yareeyay

Naqshadaynta jeex yar:

Jeexitaanka caadiga ah waa 1-2 sentimitir oo keliya, taas oo yaraynaysa xanuujinta murqaha iyo dhaawaca unugyada jilicsan.

Tignoolajiyada meelaynta saxda ah:

Saxnaanta meelaynta maqaar-galaha oo la hagaajiyay oo leh marin-hawleed gudaha ah (tusaale O-gacan, 3D-C-cudud) ama caawimada robotka (tusaale Mazor X, Globus Medical).

Dhiigbaxa qalliinka oo yaraada:

Tiknoolajiyada gelitaanka ugu yar ee galitaanka waxay yaraynaysaa halista dhaawaca xididdada dhiigga, gaar ahaan dadka waayeelka ah ama bukaannada isku dhafan.

Soo kabashada degdega ah ee qalliinka kadib

Joogitaanka isbitaalka oo gaaban:

Bukaanjiifka badankoodu waxa la sii daayaa 24-48 saacadood qalliinka ka dib, marka la barbar dhigo 3-5 maalmood qalliinka furan ee caadiga ah.

Dhaqdhaqaaqa hore:

Xanuun yar iyo ilaalinta muruqa oo wanaagsan ayaa u oggolaanaysa bukaanada inay si dhaqso ah ugu soo laabtaan hawlahooda maalmeed.

Hagaajinta biomechanical

Codsiyada alaabta cusub:

tusaale 3D daabacaadda titanium alloys, PEEK (polyether ether ketone) alaabta si loo gaaro modules of barti u dhow kan lafta iyo in la yareeyo waji-xidhka stress.

Nidaamyada xasilinta firfircoon:

Qaar ka mid ah implants (tusaale Dynesys, Coflex) waxay ilaalinayaan dhaqdhaqaaqa laf dhabarta waxayna yareeyaan khatarta ah inay xumaadaan qaybta ku xigta.

Tilmaamo fidsan

Daboolida cuduro kala duwan oo laf-dhabarta ah sida cudurrada saxanka ee xumaaday, stenosis laf-dhabarka lumbar, spondylolisthesis khafiif ah iyo jabka vertebral.

临床案列

Kuwa soo socda waa kiisas cilmi-baaris oo wakiil ah sannadihii u dambeeyay:


1. Tijaabada la xakameynayo ee la kala soocay ee isku-dhafka laf-dhabarka lumbar (TLIF)

Nakhshad waxbarasho:

Xarunta dhexe ee mustaqbalka ee RCT (2022) isbarbardhigga MIS-TLIF (ugu yar ee duulaanka ah) iyo TLIF furan.

Cabbirka Tusaalaha:

120 bukaan oo qaba cudurka laf-dhabarka laf-dhabarka ee laf-dhabarta.

Natiijooyinka:

Waqtiga qaliinka:
wax yar ka dheer kooxda MIS (macnaha 150 min vs. 130 min), laakiin 60% ka yar dhiigbax (<100 ml vs. 250 ml).
Xanuunka qaliinka kadib:
50% hoos u dhac ku yimid buundooyinka VAS 1 usbuuc ka dib qaliinka ee kooxda MIS, ma jiro farqi weyn oo u dhexeeya labada kooxood 3 bilood ka dib.
Heerka isku-dhafka:
1 sano ka dib qalliinka CT ayaa muujisay> 90% heerka fiyuuska ee labada kooxood.

Dhibaatooyinka:

Heerka caabuqa 2% ee kooxda MIS vs. 8% kooxda furan.

2. Daraasad dabagal ah oo muddo dheer ah oo ku saabsan nidaamka xasilinta firfircoon (Coflex)

Nakhshad waxbarasho:

Daraasad dabagal ah oo 5-sano ah oo Yurub ah (2021) qiimeynta ku dhejinta Coflex ee daaweynta laf-dhabarka laf-dhabarka.

Cabbirka Tusaalaha:

80 bukaan.

NATIIJADA:

Horumarin hawleed:
ODI (tusaha cilladda) ayaa hoos uga dhacday dhibcaha 45 ee gundhigga ilaa 20 dhibcood 5 sano.
QAYBTA DERISKA:
Kaliya 12% bukaannada ayaa soo saaray dhibaatooyinka qaybta ku xiga, oo aad uga hooseeya fiyuuska caadiga ah (~ 30%).
Heerka dib u hawlgalinta:
wadarta 5-sano ee dib u shaqaynta ee 8%, badi ahaan ay ugu wacan tahay dabcinta maqaar-galaha (4%) ama soo noqnoqoshada calaamadaha.


3. Barashada xarumaha badan ee qalabka MIS ee uu caawiyay robot-ka

Nakhshad waxbarasho:

daraasad dib-u-eegis ah oo la daabacay 2023 si loo falanqeeyo natiijooyinka meelaynta muraayadaha MIS ee gargaarka robotka ee Mazor.

Cabbirka Tusaalaha:

500 oo meelaynta isku-xidhka ah (laf-dhabarta thoracolumbar).

Natiijooyinka:

Saxnaanta:
98.6% boosaska isku xirka waxay ahaayeen kuwo lagu qanco (Gertzbein-Robbins darajada A/B).
Dhibaatooyinka:
Heerka dhaawaca xididka neerfaha 0.4% marka la barbar dhigo 3-5% meelaynta gacanta xorta ah ee caadiga ah.


Wixii macluumaad dheeraad ah oo ku saabsan aqoonta alaabta iyo faahfaahinta, fadlan nala soo xiriir!

Nala soo xidhiidh

La tasho khabiirada lafaha ee CZMEDITECH

Waxaan kaa caawineynaa inaad ka fogaato dabinnada si aad u gaarsiiso tayada oo aad qiimeyso baahidaada lafaha, wakhtiga iyo miisaaniyada.
Hal qayb oo ka mid ah Changzhou Meditech Technology Co., Ltd.

Adeegga

Weydiin Hadda
Xuquuqda daabacaadda 2023 CHANGZHOU MEDITECH TECHNOLOGY CO., LTD. XUQUUQDA OO DHAN.